A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining

ROWLEY, JANET D.·1973·Nature
DOI 10.1038/243290a0

Cited by (1,005)

Items 501–600 of 1,005

  1. Localization of the human c-sis oncogene in Ph1-positive and Ph1- negative chronic myelocytic leukemia by in situ hybridization
    CR Bartram, Annelies de Klein, A Hagemeijer, Gerard C. Grosveld, Nora Heisterkamp, John Groffen · 1984 · Blood
  2. JAK of all trades: JAK2-STAT5 as novel therapeutic targets in BCR-ABL1+ chronic myeloid leukemia
    Wolfgang Warsch, Christoph Walz, Veronika Sexl · 2013 · Blood
  3. Targeting abnormal DNA double-strand break repair in tyrosine kinase inhibitor-resistant chronic myeloid leukemias
    Lisa A. Tobin, C Robert, Aaron P. Rapoport, Ivana Gojo, Maria R. Baer, Alan E. Tomkinson, Feyruz Virgilia Rassool · 2012 · Oncogene
  4. In vitro efficacy of combined treatment depends on the underlying mechanism of resistance in imatinib-resistant Bcr-Abl–positive cell lines
    Paul Graf La Rosée, Kara J. Johnson, Amie S. Corbin, Eric P. Stoffregen, Erika M. Mosesón, Stephanie G. Willis, Michael Mauro, Junia V. Melo, Michael W. Deininger, Brian J. Druker · 2003 · Blood
  5. The impact of chromosomal rearrangements on regulation of gene expression
    Louise Harewood, Peter Fraser · 2014 · Human Molecular Genetics
  6. Crizotinib in the treatment of non-small-cell lung cancer
    Patrick M. Forde, Charles M. Rudin · 2012 · Expert Opinion on Pharmacotherapy
  7. The effect of dose increase of imatinib mesylate in patients with chronic or accelerated phase chronic myelogenous leukemia with inadequate hematologic or cytogenetic response to initial treatment.
    Jeffrey A. Zonder, Pamela Pemberton, Helen Brandt, Anwar N. Mohamed, Charles Alan Schiffer · 2003 · PubMed
  8. Female phenotype and multiple abnormalities in sibs with a Y chromosome and partial X chromosome duplication: H--Y antigen and Xg blood group findings.
    R Bernstein, T Jenkins, Bronwen Dawson, J Wagner, G Dewald, G C Koo, S S Wachtel · 1980 · Journal of Medical Genetics
  9. The structure of mutation in mammalian cells
    Mark Meuth · 1990 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  10. From Tissue-Agnostic to N-of-One Therapies: (R)Evolution of the Precision Paradigm
    Jacob J. Adashek, Vivek Subbiah, Razelle Kurzrock · 2020 · Trends in cancer
  11. Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia
    Francesco Onida, Greg Ball, Hagop M. Kantarjian, Terry L. Smith, Armand B. Glassman, Maher X. Albitar, Barbara Scappini, Mary Beth Rios, Michael J. Keating, Miloslav Beran · 2002 · Cancer
  12. The bone marrow microenvironment as a sanctuary for minimal residual disease in CML
    Rajesh R. Nair, Joel Hassan G. Tolentino, Lori Hazlehurst · 2010 · Biochemical Pharmacology
  13. Insights from pre-clinical studies for new combination treatment regimens with the Bcr-Abl kinase inhibitor imatinib mesylate (Gleevec/Glivec) in chronic myelogenous leukemia: a translational perspective
    Paul Graf La Rosée, Michael E O'Dwyer, Brian J. Druker · 2002 · Leukemia
  14. Src-family kinases in the development and therapy of Philadelphia chromosome-positive chronic myeloid leukemia and acute lymphoblastic leukemia
    Shaoguang Li · 2008 · Leukemia & lymphoma/Leukemia and lymphoma
  15. Integration of the cytogenetic map with the draft human genome sequence
    Terrence S. Furey · 2003 · Human Molecular Genetics
  16. Acute nonlymphocytic leukemia in adults: correlations with Q-banded chromosomes
    HM Golomb, JW Vardiman, JD Rowley · 1976 · Blood
  17. Analysis of breakpoints within the bcr gene and their correlation with the clinical course of Philadelphia-positive chronic myelogenous leukemia
    Mordechai Shtalrid, Moshe Talpaz, Razelle Kurzrock, H Kantarjian, José Manuel Trujillo, Jordan U. Gutterman, Galina Yoffe, Mark B. Blick · 1988 · Blood
  18. Non-random occurrence of 7–14 translocations in human lymphocyte cultures
    J. P. WELCH, C. L. Y. LEE · 1975 · Nature
  19. Chromosomal assignment of the human homologues of feline sarcoma virus and avian myeloblastosis virus onc genes.
    Riccardo Dalla‐Favera, Genoveffa Franchini, Stefano Martinotti, Flossie Wong‐Staal, Robert C. Gallo, Carlo Maria Croce · 1982 · Proceedings of the National Academy of Sciences
  20. cDNA sequence for human bcr, the gene that translocates to the abl oncogene in chronic myeloid leukaemia.
    Iswar K. Hariharan, Jerry M. Adams · 1987 · The EMBO Journal
  21. IL1RAP antibodies block IL-1-induced expansion of candidate CML stem cells and mediate cell killing in xenograft models
    Ågerstam, Helena, Hansen, Nils, von Palffy, Sofia, Sandén, Carl, Reckzeh, Kristian, Karlsson, Christine, Lilljebjörn, Henrik, Landberg, Niklas, Askmyr, Maria, Högberg, Carl et al. · 2016 · Blood
  22. Lipid nanoparticle-mediated siRNA delivery for safe targeting of human CML in vivo
    Nidhi Jyotsana, Amit Kumar Sharma, Anuhar Chaturvedi, Ramachandramouli Budida, Michaela Scherr, Florian C. Kuchenbauer, Robert M. Lindner, Fatih Noyan, Kurt‐Wolfram Sühs, Martin Stangel et al. · 2019 · Annals of Hematology
  23. Sequencing Structural Variants in Cancer for Precision Therapeutics
    Geoff Macintyre, Bauke Ylstra, James D. Brenton · 2016 · Trends in Genetics
  24. Association of a chromosomal 3;21 translocation with the blast phase of chronic myelogenous leukemia
    CM Rubin, Richard A. Larson, MA Bitter, John J. Carrino, Michelle M. Le Beau, MO Diaz, JD Rowley · 1987 · Blood
  25. Clustering of aberrations to specific chromosomes in human neoplasms:
    Felix Mitelman, Göran Levan · 2009 · Hereditas
  26. Fusion genes in solid tumors: an emerging target for cancer diagnosis and treatment
    Brittany C. Parker, Wei Zhang · 2013 · 癌症：英文版
  27. MicroRNAs mediated regulation of MAPK signaling pathways in chronic myeloid leukemia
    Chiranjib Chakraborty, Ashish Ranjan Sharma, Bidhan Chandra Patra, Manojit Bhattacharya, Garima Sharma, Sang‐Soo Lee · 2016 · Oncotarget
  28. The history of myeloproliferative disorders: before and after Dameshek
    Ayalew Tefferi · 2007 · Leukemia
  29. The site of the breakpoint within the bcr is a prognostic factor in Philadelphia-positive CML patients [see comments]
    Ken Mills, Elaine D. MacKenzie, GD Birnie · 1988 · Blood
  30. The Use of Cell Markers in The Study of Human Hematopoietic Neoplasia
    Wendy H. Raskind, Philip J. Fialkow · 1987 · Advances in cancer research
  31. Alteration of cellular and immune‐related properties of bone marrow mesenchymal stem cells and macrophages by K562 chronic myeloid leukemia cell derived exosomes
    Nazli Jafarzadeh, Zohreh Safari, Majid Pornour, Naser Amirizadeh, Mehdi Forouzandeh Moghadam, Majid Sadeghizadeh · 2018 · Journal of Cellular Physiology
  32. The landscape of chimeric RNAs in non-diseased tissues and cells
    Sandeep Singh, Fujun Qin, Shailesh Kumar, Justin Elfman, Emily Lin, Lam-Phong Pham, Amy X. Yang, Hui Li · 2020 · Nucleic Acids Research
  33. Selective Expansion of Primitive Normal Hematopoietic Cells in Cytokine-Supplemented Cultures of Purified Cells From Patients With Chronic Myeloid Leukemia
    Andreas Leo Petzer, Connie J. Eaves, M. J. Barnett, Allen C. Eaves · 1997 · Blood
  34. Identification of copy number variations and translocations in cancer cells from Hi-C data
    Chakraborty, Abhijit, Ay, Ferhat · 2018 · Bioinformatics
  35. Clonal evolution in chronic myelogenous leukemia
    Jörge E. Cortes, Michael E O'Dwyer · 2004 · Hematology/Oncology Clinics of North America
  36. Chronic myelogenous leukemia: A review and update of therapeutic strategies
    Guillermo Garcia‐Manero, Stefan H Faderl, Susan Mary O'Brien, Jörge E. Cortes, Moshe Talpaz, Hagop M. Kantarjian · 2003 · Cancer
  37. Genomics of chronic neutrophilic leukemia
    Julia E. Maxson, Jeffrey W Tyner · 2016 · Blood
  38. Chromosome abnormalities in cancer
    Janet D. Rowley · 1980 · Cancer Genetics and Cytogenetics
  39. bcr-abl RNA in patients with chronic myelogenous leukemia
    Emma Shtivelman, Gale Rp, Orna Dreazen, Alan Berrebi, Rina Zaizov, Ichiro Kubonishi, Ichiro Miyoshi, Eli Canaani · 1987 · Blood
  40. Etiology of cancer as studied in the platyfish-swordtail system
    Annerose Anders, Fritz Anders · 1978 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  41. Requirement for antiapoptotic MCL-1 in the survival of BCR-ABL B-lineage acute lymphoblastic leukemia
    Brian S. Koss, Jeffrey B. Morrison, Rhonda M. Perciavalle, Harpreet Singh, Jerold E. Rehg, Richard Thomas Williams, Joseph T. Opferman · 2013 · Blood
  42. How I treat Philadelphia chromosome–positive acute lymphoblastic leukemia
    Farhad Ravandi · 2018 · Blood
  43. Activation of a novel Bcr/Abl destruction pathway by WP1130 induces apoptosis of chronic myelogenous leukemia cells
    Geoffrey A. Bartholomeusz, Moshe Talpaz, Vaibhav Kapuria, Ling Yuan Kong, Shimei Wang, Zeev E. Estrov, Waldemar Priebe, Ji Yuan Wu, Nicholas J. Donato · 2007 · Blood
  44. Shifting paradigms: the seeds of oncogene addiction
    Charles L. Sawyers · 2009 · Nature Medicine
  45. Targeting of heat shock protein 32 (Hsp32)/heme oxygenase-1 (HO-1) in leukemic cells in chronic myeloid leukemia: a novel approach to overcome resistance against imatinib
    Matthias Mayerhofer, Karoline Veronika Gleixner, Julia Mayerhofer, Gregor Hoermann, Eva Jaeger, Karl J. Aichberger, René G. Ott, Khaled F. Greish, Hideaki Nakamura, Sophia V. Derdak et al. · 2007 · Blood
  46. Clinical Targeting of Mutated and Wild-Type Protein Tyrosine Kinases in Cancer
    Justin M. Drake, John K. Lee, Owen N. Witte · 2014 · Molecular and Cellular Biology
  47. Sustained Complete Molecular Remissions After Treatment With Imatinib-Mesylate in Patients With Failure After Allogeneic Stem Cell Transplantation for Chronic Myelogenous Leukemia: Results of a Prospective Phase II Open-Label Multicenter Study
    Georg Heß, Donald Werner Bunjes, W. Siegert, Rainer Schwerdtfeger, Georg Ledderose, Barbara Waßmann, Guido Kobbe, Martin Bornhäuser, Andreas Hochhaus, Andrew J. Ullmann et al. · 2005 · Journal of Clinical Oncology
  48. Selective interactions of transforming and normal abl proteins with ATP, tyrosine-copolymer substrates, and tyrphostins.
    Mordechai Anafi, Aviv Gazit, Chaim Gilon, Yinon Ben‐Neriah, Alexander Levitzki · 1992 · Journal of Biological Chemistry
  49. p130Cas: A key signalling node in health and disease
    Barrett, Angela, Pellet-Many, Caroline, Zachary, Ian C., Evans, Ian M., Frankel, Paul · 2013 · Cellular Signalling
  50. The Antiproliferative Activity of Kinase Inhibitors in Chronic Myeloid Leukemia Cells Is Mediated by FOXO Transcription Factors
    Francesca Pellicano, Mary T. Scott, G. Vignir Helgason, Lisa E. M. Hopcroft, Elaine K. Allan, Mark Aspinall-O’Dea, Mhairi Copland, Andrew Pierce, Brian J.P. Huntly, Anthony David Whetton et al. · 2014 · Stem Cells
  51. Historical and Clinical Perspectives on Chromosomal Translocations
    Ellen Wilch, Cynthia Casson Morton · 2018 · Advances in experimental medicine and biology
  52. Acquired loss of p53 induces blastic transformation in p210bcr/abl-expressing hematopoietic cells: a transgenic study for blast crisis of human CML
    Hiroaki Honda, Toshikazu Ushijima, Kuniko Wakazono, Hideaki Oda, Yuji Tanaka, Shinichi Aizawa, Takatoshi Ishikawa, Yoshio Yazaki, Hisamaru Hirai · 2000 · Blood
  53. Novel chimaeric protein expressed in Philadelphia positive acute lymphoblastic leukaemia
    Lesley C. Walker, Trivadi Sundaram Ganesan, Susheela Dhut, Barbara Gibbons, T. Andrew Lister, Jonathan B. Rothbard, Bryan D. Young · 1987 · Nature
  54. Abnormalities of chromosome 1 in myeloproliferative disorders
    Janet D. Rowley · 1975 · Cancer
  55. The isolation of a human Ig Vλ gene from a recombinant library of chromosome 22 and estimation of its copy number
    Melanie Anderson, Marie‐France Szajnert, Kaplan Jc, L A McColl, Bryan D. Young · 1984 · Nucleic Acids Research
  56. Chronic myeloid leukemia stem cells: targeting therapeutic implications
    Hanieh Mojtahedi, Niloufar Yazdanpanah, Nima Rezaei · 2021 · Stem Cell Research & Therapy
  57. Targeting PI 3‐kinase ( PI 3 K ), AKT and m TOR axis in lymphoma
    James Stewart Blachly, Robert A. Baiocchi · 2014 · British Journal of Haematology
  58. Characterization of cancer stem cells in chronic myeloid leukaemia
    Heather G. Jørgensen, Tessa L. Holyoake · 2007 · Biochemical Society Transactions
  59. Historical prospective of human cytogenetics: from microscope to microarray
    Dominique Smeets · 2004 · Clinical Biochemistry
  60. The age incidence of chronic myeloid leukemia can be explained by a one-mutation model
    Franziska Michor A, Yoh Iwasa, Martin A. Nowak · 2006 · Proceedings of the National Academy of Sciences
  61. Low-Level Expression of Proapoptotic Bcl-2–Interacting Mediator in Leukemic Cells in Patients with Chronic Myeloid Leukemia: Role of BCR/ABL, Characterization of Underlying Signaling Pathways, and Reexpression by Novel Pharmacologic Compounds
    Karl J. Aichberger, Matthias Mayerhofer, Maria‐Theresa Krauth, Anja Vales, Rudin Kondo, Sophia V. Derdak, Winfried Franz Pickl, Edgar Selzer, Michael W. Deininger, Brian J. Druker et al. · 2005 · Cancer Research
  62. Philadelphia chromosome-negative chronic myelogenous leukemia without breakpoint cluster region rearrangement: a chronic myeloid leukemia with a distinct clinical course
    Razelle Kurzrock, HM Kantarjian, Mordechai Shtalrid, JU Gutterman, Moshe Talpaz · 1990 · Blood
  63. Partial Deletion of Long Arm of Chromosome 17
    H M Golomb · 1976 · Archives of Internal Medicine
  64. Genomics and the History of Precision Oncology
    Deborah B. Doroshow, James H. Doroshow · 2019 · Surgical Oncology Clinics of North America
  65. ABC transporter A3 facilitates lysosomal sequestration of imatinib and modulates susceptibility of chronic myeloid leukemia cell lines to this drug
    Bjoern Chapuy, M. V. Panse, Ulf K Radunski, Raphael Koch, Dirk Wenzel, Nobuya Inagaki, Detlef Thomas Haase, Lorenz H. P. Trümper, Gerald Georg Wulf · 2009 · Haematologica
  66. Chimeric RNAs generated by intergenic splicing in normal and cancer cells
    Kasey Jividen, Hui Li · 2014 · Genes Chromosomes and Cancer
  67. Fusion genes and their discovery using high throughput sequencing
    Matti Annala, B. C. Parker, Weinan Zhang, Matti Nykter · 2013 · Cancer Letters
  68. Persistence of BCR-ABL genomic rearrangement in chronic myeloid leukemia patients in complete and sustained cytogenetic remission after interferon-α therapy or allogeneic bone marrow transplantation
    Jean‐Claude Chomel, Françoise Brizard, Anne Veinstein, Jéröme Rivet, Alain Sadoun, Alain Kitzis, François Guilhot, A. Brizard · 2000 · Blood
  69. Intracellular antibody capture technology: application to selection of intracellular antibodies recognising the BCR-ABL oncogenic protein
    Eric Tse, M.Natividad Lobato, Alan Mark Forster, Tomoyuki U Tanaka, Grace T.Y Chung, Terence Howard Rabbitts · 2002 · Journal of Molecular Biology
  70. Genetic predisposition to cancer with special reference to mutagen sensitivity
    T. C. Hsü · 1987 · In Vitro Cellular & Developmental Biology - Plant
  71. CHROMOSOME ABNORMALITIES IN HUMAN LEUKEMIA
    Janet D. Rowley · 1980 · Annual Review of Genetics
  72. The correlation of breakpoint cluster region rearrangement and p210 phl/abl expression with morphological analysis of Ph-negative chronic myeloid leukemia and other myeloproliferative diseases
    LM Wiedemann, Kimmo K. Karhi, MK Shivji, SI Rayter, SM Pegram, G Dowden, David H Bevan, AJ Will, DA Galton, LC Chan · 1988 · Blood
  73. AmpliconReconstructor integrates NGS and optical mapping to resolve the complex structures of focal amplifications
    Jens Luebeck, Ceyda Çoruh, Siavash R. Dehkordi, Joshua T. Lange, Kristen M. Turner, Viraj Deshpande, Dave A. Pai, Chao Zhang, Utkrisht Rajkumar, Julie A. Law et al. · 2020 · Nature Communications
  74. Potential G-quadruplex formation at breakpoint regions of chromosomal translocations in cancer may explain their fragility
    Vijeth K. Katapadi, Mridula Nambiar, Sathees C. Raghavan · 2012 · Genomics
  75. Amplified C lambda and c-abl genes are on the same marker chromosome in K562 leukemia cells.
    Jules R. Selden, Beverly S. Emanuel, E Wang, Linda A. Cannizzaro, Antonio Pierangelo Palumbo, Jan Erikson, Peter C. Nowell̀, G Rovera, Carlo Maria Croce · 1983 · Proceedings of the National Academy of Sciences
  76. Transformation by Polyoma Virus and Simian Virus 40
    Joe Sambrook · 1981 · Advances in cancer research
  77. Evolving concepts of tumor heterogeneity
    Victoria R. Zellmer, Siyuan Zhang · 2014 · Cell & Bioscience
  78. Front-Line and Salvage Therapies With Tyrosine Kinase Inhibitors and Other Treatments in Chronic Myeloid Leukemia
    Jörge E. Cortes, Andreas Hochhaus, Timothy P. Hughes, Hagop M. Kantarjian · 2011 · Journal of Clinical Oncology
  79. Inflammation-Induced Oxidative Stress Mediates Gene Fusion Formation in Prostate Cancer
    Ram Shankar Mani, M. Asif Amin, Xiangyi Li, Shanker Kalyana Sundaram, Brendan A. Veeneman, Lei Wang, Aparna Ghosh, Adam J. Aslam, Susmita Gurjar Ramanand, Bradley James Rabquer et al. · 2016 · Cell Reports
  80. Expression of c-abl in Philadelphia-positive acute myelogenous leukemia
    Razelle Kurzrock, Mordechai Shtalrid, Moshe Talpaz, William S. Kloetzer, J U Gutterman · 1987 · Blood
  81. Failure of CDKN2A/B (INK4A/B–ARF)-mediated tumor suppression and resistance to targeted therapy in acute lymphoblastic leukemia induced by BCR-ABL
    Charles Grenfell Mullighan, Richard Thomas Williams, James R. Downing, Charles J. Sherr · 2008 · Genes & Development
  82. Inducible activation of CEBPB, a gene negatively regulated by BCR/ABL, inhibits proliferation and promotes differentiation of BCR/ABL-expressing cells
    C. Guerzoni · 2006 · Blood
  83. How I treat Philadelphia chromosome–positive acute lymphoblastic leukemia
    Adele Kay Fielding · 2010 · Blood
  84. Historical and Current Highlights in Radiation Biology: Has Anything Important Been Learned by Irradiating Cells?
    Joel S. Bedford, William C. Dewey · 2002 · Radiation Research
  85. Chronic Myelogenous Leukemia
    Mamta Kalidas · 2001 · JAMA
  86. Dysmyelopoietic syndrome: sequential clinical and cytogenetic studies
    RA Streuli, JR Testa, JW Vardiman, Uri Mintz, HM Golomb, JD Rowley · 1980 · Blood
  87. Implicating the bcr/abl Gene in the Pathogenesis of Philadelphia Chromosome-Positive Human Leukemia
    George Q. Daley, Yinon Ben‐Neriah · 1991 · Advances in cancer research
  88. Exploration of the gene fusion landscape of glioblastoma using transcriptome sequencing and copy number data
    Nameeta Shah, Michael Lankerovich, Hwahyung Lee, Jae‐Geun Yoon, Brett Schroeder, Greg Foltz · 2013 · BMC Genomics
  89. A non-Smad mechanism of fibroblast activation by transforming growth factor-β via c-Abl and Egr-1: selective modulation by imatinib mesylate
    Swati Bhattacharyya, W Ishida, Minghua Wu, Mark C. Wilkes, Yasuji Mori, Monique Hinchcliff, Edward B. Leof, John Varga · 2009 · Oncogene
  90. Low BCR-ABL expression levels in hematopoietic precursor cells enable persistence of chronic myeloid leukemia under imatinib
    Ashu Kumari, Cornelia A. Brendel, Andreas Hochhaus, Andreas Neubauer, Andreas Burchert · 2011 · Blood
  91. Reanalysis of RNA-Sequencing Data Reveals Several Additional Fusion Genes with Multiple Isoforms
    Sara Kangaspeska, Susanne Hultsch, Henrik Edgren, Daniel Nicorici, Astrid Murumägi, Olli Kallioniemi · 2012 · PLoS ONE
  92. High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progression
    Jacqueline Boultwood, J Perry, R. Zaman, C Fernandez-Santamaria, Tim J. Littlewood, Rajko Kušec, Andrea Pellagatti, L Wang, Richard E. Clark, James S. Wainscoat · 2010 · Leukemia
  93. Cytogenetic Evidence for Splenic Origin of Blastic Transformation in Chronic Myeloid Leukaemia
    Felix Mitelman, Lars Peter Andreas Brandt, Per Gunnar Nilsson · 1974 · Scandinavian Journal of Haematology
  94. Treatment-free remission in CML: who, how, and why?
    François‐Xavier Mahon · 2017 · Hematology
  95. Chronic Myeloid Leukemia in 2020
    Rüdiger Hehlmann · 2020 · HemaSphere
  96. Unfinished Stories on Viral Quasispecies and Darwinian Views of Evolution
    Antonio Más, Cecilio López‐Galíndez, Isabel Cacho, Jordi Gómez, Miguel Ángel Martı́nez · 2010 · Journal of Molecular Biology
  97. Resistant mutations in CML and Ph+ALL – role of ponatinib
    Carol S. Lim, Geoffrey D. Miller, Benjamin J. Bruno · 2014 · Biologics
  98. A chromatin structure‐based model accurately predicts DNA replication timing in human cells
    Yevgeniy Gindin, Manuel S. Valenzuela, Mirit I. Aladjem, Paul S. Meltzer, Sven Bilke · 2014 · Molecular Systems Biology
  99. Chronic myelogenous leukemia
    Michael J. Mauro, Brian J. Druker · 2001 · Current Opinion in Oncology
  100. Hypermetaphase fluorescence in situ hybridization for quantitative monitoring of Philadelphia chromosome-positive cells in patients with chronic myelogenous leukemia during treatment
    DC Seong, HM Kantarjian, Jae Yoon Ro, Moshe Talpaz, Jie Xu, JR Robinson, AB Deisseroth, RE Champlin, MJ Siciliano · 1995 · Blood